Skip to main content

DTx Alliance

By Dave Muoio | 05:28 pm | April 08, 2020
Also: FDA COVID-19 policy allows for remote use, digital modifications to ophthalmic devices; 23andMe launches genetics study to understand varying COVID-19 responses.
By MobiHealthNews | 04:09 pm | January 16, 2020
Also: Bardy Diagnostics names Ed Vertatschisch as next COO; Sapphire Digital names Kyle Raffaniello as permanent CEO. 
By Dave Muoio and Laura Lovett | 04:45 pm | September 27, 2019
Digital therapeutic stakeholders came together at this week's DTx East conference to discuss the state of digital health investment, developing successful business models, the need for robust data and more.